Home » News » Awards & Advancement » Tracy Tsuetaki joins Parexel as senior vice president

Tracy Tsuetaki joins Parexel as senior vice president

Friday, September 5, 2014

Parexel International, a global biopharmaceutical services provider, has appointed Dr. Tracy Tsuetaki as senior vice president for peri/post-approval services and Parexel consulting. He will oversee the strategy and operational management for both businesses. He also will be on Parexel’s business review committee.

Tsuetaki joins Parexel from UnitedHealth Group, where he was group president for Optum Life Sciences. He managed the strategic regulatory and safety services organization. This encompassed pharmacovigilance, medical information, pharmacoepidemiology, risk evaluation and risk mitigation strategies. It also included regulatory affairs consulting and operations outsourcing, chemical manufacturing and control, good clinical practice and good manufacturing practice services.

Previously, he was group president of i3—Clinical Development Services, also at United Healthcare Group. He led phase I-III clinical research and strategic regulatory offerings, as well as resourcing and staffing services.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!